Coagulation Markers Market Report 2026

Coagulation Markers Market Overview

• Coagulation Markers market size has reached to $1.24 billion in 2025 • Expected to grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Rising Prevalence Of Blood Disorders Drives Growth In The Coagulation Markers Market • Market Trend: Technological Innovations in Coagulation Markers • North America was the largest region in 2025.

What Is Covered Under Coagulation Markers Market?

Coagulation markers refer to measurable substances in the blood that indicate the status of blood coagulation or clotting processes. These markers are essential in diagnosing and monitoring various coagulation disorders, assessing the risk of bleeding or thrombosis, and guiding appropriate treatment strategies. The main products of coagulation markers are the D-dimer assay and the fibrinogen assay. A D-dimer assay refers to a blood test that measures the presence of D-dimer, a protein fragment produced when a blood clot dissolves in the body. This test utilizes various sample types, such as plasma, whole blood samples, and others, employing technologies such as fluorescence immunoassay, enzyme-linked immunosorbent assay (ELISA), rapid test, and particle-enhanced immunoturbidimetric assay. It finds applications in deep venous thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), trauma, and others, and end users are hospitals, specialty clinics, academic and research institutes, and diagnostic laboratories.

What Is The Coagulation Markers Market Growth Forecast?

The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to aging population with higher clotting risk, increasing demand for rapid diagnostic decision-making, expansion of emergency and trauma care services, growing focus on preventive thrombotic risk assessment, rising adoption of advanced coagulation testing technologies. Major trends in the forecast period include rising demand for early and accurate thrombosis detection, increasing use of coagulation markers in emergency and critical care, growing adoption of rapid and point-of-care coagulation testing, expansion of coagulation marker testing in trauma and surgical settings, increasing integration of coagulation testing in routine diagnostics.

Global Coagulation Markers Market Segmentation

1) By Product: D-Dimer Assay, Fibrinogen Assay 2) By Sample Type: Plasma, Whole Blood Sample, Other Sample Types 3) By Technology: Fluorescence Immunoassay, Enzyme-Linked Immuno Sorbent Assay (ELISA), Rapid Test, Particle Enhanced Immunoturbidimetric Assay 4) By Application: Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Trauma, Other Applications 5) By End User: Hospital, Specialty Clinics, Academic And Research Institute, Diagnostics Laboratories Subsegments: 1) By D-Dimer Assay: ELISA-Based D-Dimer Assay, Lateral Flow Immunoassay D-Dimer Test, Chemiluminescent Immunoassay D-Dimer Test 2) By Fibrinogen Assay: Clauss Fibrinogen Assay, Functional Fibrinogen Assay, Automated Fibrinogen Assay

What Is The Driver Of The Coagulation Markers Market?

The rise in the prevalence of blood disorders is expected to propel the growth of the coagulation markers market going forward. Blood disorders refer to a wide range of conditions that affect the blood's ability to function correctly. The prevalence of blood disorders is growing due to aging populations, increased awareness, and improved diagnostic capabilities. Coagulation markers help diagnose and manage blood disorders by assessing clotting function, identifying abnormalities, and monitoring treatment effectiveness for conditions like hemophilia and thrombosis. For instance, in May 2024, according to the Leukaemia Foundation, an Australia-based non-profit organization, currently around 135,000 people in Australia are living with a blood cancer or blood disorder, with this number projected to exceed 275,000 by 2035. Therefore, an increasing prevalence of blood disorders is driving the coagulation marker industry.

Key Players In The Global Coagulation Markers Market

Major companies operating in the coagulation markers market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

Global Coagulation Markers Market Trends and Insights

Major companies operating in the coagulation markers market are focusing on developing technologically innovative solutions, such as D-dimer kits to improve the speed and accuracy of diagnosing blood clot-related conditions. D-dimer kits refer to diagnostic tools used to measure the level of D-dimer, a protein fragment produced when a blood clot dissolves, helping detect and assess clot-related disorders like deep vein thrombosis and pulmonary embolism. For instance, in July 2024, Bionote Inc., a US-based biotechnology company, launched Vcheck D-dimer 5Tests/Kit. The Vcheck D-dimer 5Tests/Kit is an immunodiagnostic tool designed for veterinary use, providing 5 tests per kit to detect D-dimer levels, a marker for blood clot formation and breakdown. It aids in diagnosing conditions like thrombosis, sepsis, and DIC in veterinary clinics.

What Are Latest Mergers And Acquisitions In The Coagulation Markers Market?

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion (£2.3 billion). The acquisition of The Binding Site Group aims to strengthen Thermo Fisher's Specialty Diagnostics portfolio by enhancing cancer diagnostics, particularly for multiple myeloma, and driving growth in the expanding diagnostics market. The Binding Site Group is a UK-based medical equipment manufacturing company that specializes in providing coagulation markers.

Regional Outlook

North America was the largest region in the coagulation markers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Coagulation Markers Market?

The coagulation markers market consists of revenues earned by entities providing services such as manufacturing and distribution of coagulation marker testing kits, diagnostic services, research and development of new coagulation markers, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The coagulation markers market also includes sales of coagulation testing kits, point-of-care testing devices, and software solutions for data management and analysis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.